Correction: Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.
Main Author: | PLOS ONE Staff |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4619721?pdf=render |
Similar Items
-
Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.
by: Alicia Romero-Lorca, et al.
Published: (2015-01-01) -
Implication of human UGT2B7, 2B15 and 2B17 in 19-norandrosterone metabolism
by: Emmanuel eStrahm, et al.
Published: (2013-06-01) -
Red wine and component flavonoids inhibit UGT2B17 <it>in vitro</it>
by: Jenkinson Carl, et al.
Published: (2012-09-01) -
Regulation of Hepatic UGT2B15 by Methylation in Adults of Asian Descent
by: Steffen G. Oeser, et al.
Published: (2018-01-01) -
Effects of CYP2D6 and UGT2B7 polymorphisms on pharmacokinetics of tamoxifen in Thai breast cancer patients
by: Areepium N, et al.
Published: (2013-08-01)